Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas

April 2, 2013 9:33 AM EDT Send to a Friend
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) said to draw interest from Glaxo (NYSE: GSK), Astellas, Cubist (Nasdaq: CBST), AstraZeneca (NYSE: AZN). Optimer might go for about $1 billion, according to reports.

Shares are ripping early.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Momentum Movers, Rumors, Trader Talk

Add Your Comment